N-methyl-(R)salsolinol as a dopaminergic neurotoxin: from an animal model to an early marker of Parkinson's disease.
A dopamine-derived 1(R), 2(N)-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydrosioquinoline [N-methyl-(R)salsolinol] was found to occur enantioselectively in human brain. This isoquinoline induced parkinsonism in rat after injection in the striatum, and the behavioral, biochemical and pathological changes were very similar to those in Parkinson's disease. N-Methyl-(R)salsolinol depleted dopamine neurons in the rat substantia nigra without necrotic tissue reaction, which may be due to the apoptotic death process, as proved by its induction of DNA damage in dopaminergic neuroblastoma SH-SY5Y cells. N-Methyl-(R)salsolinol was found to increase significantly in the cerebrospinal fluid of parkinsonian patients. All these results suggest that N-methyl-(R)salsolinol may be an endogenous neurotoxin to cause Parkinson's disease and the enzymes involved in its biosynthesis and catabolism may be endogenous factors in the pathogenesis of this disease.
Naoi
M
M
Department of Biosciences, Nagoya Institute of Technology, Japan.
Maruyama
W
W
Dostert
P
P
Hashizume
Y
Y
D000818:Animals; D015415:Biomarkers; D001921:Brain / Q000378:metabolism* / Q000473:pathology; D002460:Cell Line; D002470:Cell Survival / Q000187:drug effects; D004298:Dopamine / Q000378:metabolism; D006801:Humans; D007546:Isoquinolines / Q000378:metabolism; D008297:Male; D009498:Neurotoxins; D010300:Parkinson Disease / Q000378:metabolism* / Q000473:pathology; D010302:Parkinson Disease, Secondary / Q000378:metabolism* / Q000473:pathology; D051381:Rats; D017208:Rats, Wistar; D012490:Salsoline Alkaloids / Q000032:analysis* / Q000378:metabolism / Q000633:toxicity; D013237:Stereoisomerism; D044005:Tetrahydroisoquinolines
D015415:Biomarkers; D007546:Isoquinolines; D009498:Neurotoxins; D012490:Salsoline Alkaloids; D044005:Tetrahydroisoquinolines; C036617:salsolinol; C032837:salsoline; D004298:Dopamine